eNauka - pregled

Pregled prema Projekat Yuhan

Prikaz rezultata 1 do 2 od 2
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2022A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)Cho, BC; ...; Zaric, Bojan  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2023Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studiesLee, Y-G; ...; Zaric, B  ; ...; (broj, koautora 16)Konferencijski rad
Mp kategorija će biti prikazana naknadno.